EMA Launches Pilot for Alternatives to Animal Testing
The European Medicines Agency (EMA) has launched a voluntary data submission (VDS) pilot to advance innovative alternatives to animal testing. This initiative aims to facilitate the sharing of data generated using New Approach Methodologies (NAMs). This marks a significant step towards reducing and potentially replacing animal testing in drug development, reflecting a commitment to ethical research and potentially speeding up the availability of new medicines for EU citizens.
EMA pilot promotes ethical, innovative alternatives to animal testing in medicine.